Evidence map›Paper›PMID 32098600›Full record

Observational studyJournal of the American Heart Association2020

Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study.

Danielle E Haslam, Gina M Peloso, Mark A Herman, Josée Dupuis, Alice H Lichtenstein, Caren E Smith, Nicola M McKeown

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. 2024 KSoLA consensus on secondary dyslipidemia.The Korean journal of internal medicine · 2024
    Review
  14. 2024 KSoLA Consensus on Secondary Dyslipidemia.Journal of lipid and atherosclerosis · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Saudi journal of biological sciences · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Danielle E HaslamNutritional Epidemiology Program Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University Boston MA USA.
Gina M PelosoDepartment of Biostatistics Boston University School of Public Health Boston Massachusetts USA.
Mark A HermanDivision Of Endocrinology, Metabolism, and Nutrition Department of Medicine Duke University School of Medicine Durham NC USA.
Josée DupuisDepartment of Biostatistics Boston University School of Public Health Boston Massachusetts USA.
Alice H LichtensteinCardiovascular Nutrition Laboratory Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University Boston MA USA.
Caren E SmithNutrition and Genomics Laboratory Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University Boston MA USA.
Nicola M McKeownNutritional Epidemiology Program Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University Boston MA USA.
Tufts University · USBoston University · USDuke University · USJean Mayer Human Nutrition Research Center on Aging · US

Funding

FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
The Role of ChREBP in Fructose Induced Metabolic DiseaseR01DK100425 · NIDDK · DUKE UNIVERSITY · PI HERMAN, MARK A · 2014 to 2023
$3.6M
Nutrition &Cardiovascular Disease Training ProgramT32HL069772 · NHLBI · TUFTS UNIVERSITY BOSTON · PI LICHTENSTEIN, ALICE H · 2003 to 2017
$2.1M
Genetic predictors of metabolic responses to dairyK08HL112845 · NHLBI · TUFTS UNIVERSITY BOSTON · PI SMITH, CAREN ELIZABETH · 2013 to 2017
$474k
NCI NIH HHS T32 CA009001NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS K08 HL112845NHLBI NIH HHS T32 HL069772NIDDK NIH HHS R01 DK100425
6 · The paper itself

Abstract

Background Limited data are available on the prospective relationship between beverage consumption and plasma lipid and lipoprotein concentrations. Two major sources of sugar in the US diet are sugar-sweetened beverages (SSBs) and 100% fruit juices. Low-calorie sweetened beverages are common replacements. Methods and Results Fasting plasma lipoprotein concentrations were measured in the FOS (Framingham Offspring Study) (1991-2014; N=3146) and Generation Three (2002-2001; N=3584) cohorts. Beverage intakes were estimated from food frequency questionnaires and grouped into 5 intake categories. Mixed-effect linear regression models were used to examine 4-year changes in lipoprotein measures, and Cox proportional hazard models were used to estimate hazard ratios for incident dyslipidemia, adjusting for potential confounding factors. We found that regular (>1 serving per day) versus low (<1 serving per month) SSB consumption was associated with a greater mean decrease in high-density lipoprotein cholesterol (β±standard error -1.6±0.4 mg/dL;

Indexed as

Artificially Sweetened BeveragesBiomarkersCholesterol, HDLCholesterol, LDLDyslipidemiasFemaleFruit and Vegetable JuicesHumansIncidenceLipoproteinsLongitudinal StudiesMaleMassachusettsMiddle AgedProspective StudiesRisk AssessmentBiomarkersCholesterol, HDLCholesterol, LDLLipoproteinsTriglyceridescarbohydratesdyslipidemiafruit juicelow‐calorie sweetened beveragesnutritionobservational studysugar‐sweetened beverages

Identifiers

PMID32098600
PMCPMC7335580
OpenAlexW3008388363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.